News & Alerts
-
Jan- 2024 -2 January
Dollar Landscape of Biological Drug API Manufacturing Services – A Decade of Growth and Collaboration (2023-2033)
The Biological Drug API Manufacturing Services Market Report for 2023-2033, presented by Research and Markets, underscores key developments in the…
Read More » -
2 January
AstraZeneca and Sanofi’s Breakthrough RSV Infant Shots Approved in China
In a significant development for infant healthcare, AstraZeneca and Sanofi have announced the approval of their respiratory syncytial virus (RSV)…
Read More » -
Dec- 2023 -30 December
FDA Issues Warning and Labeling Updates for Promethazine Hydrochloride Injection Products
In an announcement targeted at Health Care Professionals, the U.S. Food and Drug Administration (FDA) has released information regarding labeling…
Read More » -
30 December
Narcolepsy Drugs Market Soars to $5.95 Billion by 2030: Sodium Oxybate Takes Center Stage in Global Forecast
The Narcolepsy Drugs Market is on an upward trajectory, projected to reach a substantial value of US$5.95 billion by 2030,…
Read More » -
30 December
Stuart Therapeutics Unveils Breakthrough Phase 3 Clinical Trial for Vezocolmitide, a Potential Game-Changer in Dry Eye Disease Treatment
Stuart Therapeutics, Inc. (“Stuart”), a cutting-edge biopharmaceutical company specializing in extracellular matrix-targeting peptide therapeutics for ophthalmic diseases, has marked a…
Read More » -
30 December
Acelyrin, Inc. Faces Wrath of Investors in Landmark Securities Class Action
Kessler Topaz Meltzer & Check, LLP has announced the initiation of a securities class action lawsuit against Acelyrin, Inc. (NASDAQ:…
Read More » -
30 December
Drugmakers to Increase Prices on Over 500 Drugs in January
According to an exclusive report by Reuters, several major pharmaceutical companies, including Pfizer, Sanofi, and Takeda Pharmaceutical, are set to…
Read More » -
30 December
MiMedx Group Receives FDA Warning Letter for Axiofill; Shares Decline 7%
MiMedx Group Inc, a biopharmaceutical company, reported on Friday that it has received a warning letter from the U.S. Food…
Read More » -
30 December
Corcept Loses Patent Dispute Against Teva, Shares Tumble
A U.S. judge ruled in favor of Teva Pharmaceutical Industries in a patent infringement lawsuit filed by Corcept Therapeutics, leading…
Read More » -
30 December
McKinsey Agrees to Pay $78 Million in Final Settlement Over Alleged Role in U.S. Opioid Epidemic
Consulting firm McKinsey & Co has reached a final settlement of $78 million to resolve claims made by U.S. health…
Read More »